Pfizer Ltd (London)

LONDON - Pfizer welcomes today's launch of the Life Sciences Blueprint by the Office for Life Sciences, and believes that the proposals, if implemented in full measure, will materially improve the UK environment for the life sciences sector, support the NHS in its drive for innovation, and deliver a higher standard of care for UK patients.